Insulin receptor substrate-1 is over-expressed in glycogenotic but not in amphophilic preneoplastic hepatic foci induced in rats by N-nitrosomorpholine and dehydroepiandrosterone

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 75-79

  Nehrbass, Dirk ^a   Klimek, Fritz ^a   Bannasch, Peter ^a   Mayer, Doris ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cell lineages; Dehydroepiandrosterone; Hepatocarcinogenesis; Insulin receptor substrate 1; Phenotypic modulation; Preneoplasia; Rat liver

Indexed keywords

AMPHOPHILE; INSULIN RECEPTOR SUBSTRATE 1; NITROSOMORPHOLINE; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOGEN SYNTHESIS; IMMUNOCYTOCHEMISTRY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENOMA, LIVER CELL; ANIMALS; CARCINOMA, HEPATOCELLULAR; DEHYDROEPIANDROSTERONE; FEMALE; GLYCOGEN; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; NITROSAMINES; PHOSPHOPROTEINS; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032971785     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00095-6     Document Type: Article

References (16)

1. Bannasch P. Pathogenesis of hepatocellular carcinoma: Sequential cellular, molecular, and metabolic changes. Prog. Liver Dis. 14:1996;161-197.
2. Bannasch P., Hacker H.J., Klimek F., Mayer D. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv. Enzyme Regul. 22:1984;97-121.
3. Bannasch P., Klimek F., Mayer D. Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J. Bioenerg. Biomembr. 29:1997;303-313.
4. Mayer D., Metzger C., Leonetti P., Beier K., Benner A., Bannasch P. Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int. J. Cancer (Pred. Oncol.). 79:1998;232-240.
5. Weber E., Moore M.A., Bannasch P. Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone. Carcinogenesis. 9:1988;1191-1195.
6. Metzger C., Mayer D., Hoffmann H., Bocker T., Hobe G., Benner A., Bannasch P. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol. Pathol. 23:1995;591-605.
7. Rao M.S., Subbarao V., Yeldandi A.V., Reddy J.K. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res. 52:1992;2977-2979.
8. Metzger C., Bannasch P., Mayer D. Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone. Cancer Lett. 121:1997;125-131.
9. Mayer D. Carcinogenic and anticarcinogenic effects of dehydroepiandrosterone in the liver of male and female rats. Aging Male. 1:1998;56-66.
10. Nehrbass D., Klimek F., Bannasch P. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am. J. Pathol. 152:1998;341-345.
11. Myers M.G. Jr., White M.F. Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol. 36:1996;615-658.
12. Christiansen K., Carlsen J. Insertion of functional intact insulin receptors into hepatocytes. Cell. Signal. 7:1995;583-589.
13. Sasaki Y., Zhang X.F., Nishiyama M., Avruch J., Wands J.R. Expression and phosphorylation of insulin receptor substrate 1 during rat liver regeneration. J. Biol. Chem. 268:1993;3805-3808.
14. Mayer D., Reuter S., Hoffmann H., Bocker T., Bannasch P. Dehydroepiandrosterone reduces expression of glycolytic and gluconeogenic enzymes in the liver of male and female rats. Int. J. Oncol. 8:1996;1069-1078.
15. Yamauchi T., Tobe K., Tamemoto H., Ueki K., Kaburagi Y., Yamamoto-Honda R., Takahashi Y., Yoshizawa F., Aizawa S., Akanuma Y., Sonenberg N., Yazaki Y., Kadowaki T. Insulin signalling and insulin actions in the muscle and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell Biol. 16:1996;3074-3084.
16. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G.I., Bonner-Weir S., White M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:1998;900-904.